256 related articles for article (PubMed ID: 18426818)
1. Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients.
Machado MC; Valeria de Sa S; Correa-Giannella ML; Giorgi RR; Pereira MA; Cescato VA; Giannella-Neto D; Salgado LR
Eur J Endocrinol; 2008 May; 158(5):605-13. PubMed ID: 18426818
[TBL] [Abstract][Full Text] [Related]
2. In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression.
Machado MC; Sá SV; Goldbaum TS; Catania M; Campos VC; Corrêa-Giannella ML; Giannella-Neto D; Salgado LR
J Endocrinol Invest; 2007 Apr; 30(4):334-40. PubMed ID: 17556872
[TBL] [Abstract][Full Text] [Related]
3. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
[TBL] [Abstract][Full Text] [Related]
4. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
[TBL] [Abstract][Full Text] [Related]
5. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
6. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Correa-Silva SR; Nascif SO; Lengyel AM
Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
[TBL] [Abstract][Full Text] [Related]
7. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing's syndrome.
Machado MC; de Sa SV; Domenice S; Fragoso MC; Puglia P; Pereira MA; de Mendonça BB; Salgado LR
Clin Endocrinol (Oxf); 2007 Jan; 66(1):136-42. PubMed ID: 17201813
[TBL] [Abstract][Full Text] [Related]
8. Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor.
Sekiguchi Y; Miyamoto Y; Kasahara I; Hara Y; Tani Y; Doi M; Hirata Y
Endocr J; 2015; 62(5):441-7. PubMed ID: 25819222
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
10. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
11. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
[TBL] [Abstract][Full Text] [Related]
12. [Bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
Belli S; Oneto A; Mendaro E
Rev Med Chil; 2007 Sep; 135(9):1095-102. PubMed ID: 18064362
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
Coiro V; Volpi R; Capretti L; Caffarri G; Chiodera P
J Intern Med; 2000 Jun; 247(6):667-73. PubMed ID: 10886488
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome.
Castinetti F; Morange I; Dufour H; Jaquet P; Conte-Devolx B; Girard N; Brue T
Eur J Endocrinol; 2007 Sep; 157(3):271-7. PubMed ID: 17766708
[TBL] [Abstract][Full Text] [Related]
15. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
[TBL] [Abstract][Full Text] [Related]
16. Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro.
Arlt W; Dahia PL; Callies F; Nordmeyer JP; Allolio B; Grossman AB; Reincke M
Clin Endocrinol (Oxf); 1997 Nov; 47(5):623-7. PubMed ID: 9425403
[TBL] [Abstract][Full Text] [Related]
17. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
18. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
[TBL] [Abstract][Full Text] [Related]
19. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.
Arnaldi G; Mancini T; Kola B; Appolloni G; Freddi S; Concettoni C; Bearzi I; Masini A; Boscaro M; Mantero F
J Clin Endocrinol Metab; 2003 Dec; 88(12):5834-40. PubMed ID: 14671177
[TBL] [Abstract][Full Text] [Related]
20. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
